CN1890232B - 类黄酮衍生物 - Google Patents
类黄酮衍生物 Download PDFInfo
- Publication number
- CN1890232B CN1890232B CN2004800361574A CN200480036157A CN1890232B CN 1890232 B CN1890232 B CN 1890232B CN 2004800361574 A CN2004800361574 A CN 2004800361574A CN 200480036157 A CN200480036157 A CN 200480036157A CN 1890232 B CN1890232 B CN 1890232B
- Authority
- CN
- China
- Prior art keywords
- sidastrum
- extract
- goods
- compound
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
Abstract
Description
Claims (19)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10357004A DE10357004A1 (de) | 2003-12-05 | 2003-12-05 | Flavonoid-Derivat |
DE10357004.7 | 2003-12-05 | ||
PCT/EP2004/012538 WO2005054222A2 (de) | 2003-12-05 | 2004-11-05 | Flavonoid-derivat |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1890232A CN1890232A (zh) | 2007-01-03 |
CN1890232B true CN1890232B (zh) | 2010-05-26 |
Family
ID=34625583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2004800361574A Expired - Fee Related CN1890232B (zh) | 2003-12-05 | 2004-11-05 | 类黄酮衍生物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US7588783B2 (zh) |
EP (1) | EP1689734B1 (zh) |
JP (1) | JP2007513100A (zh) |
CN (1) | CN1890232B (zh) |
AT (1) | ATE402158T1 (zh) |
DE (2) | DE10357004A1 (zh) |
ES (1) | ES2308311T3 (zh) |
WO (1) | WO2005054222A2 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060275278A1 (en) * | 2005-06-02 | 2006-12-07 | Choy Camus K M | Method and ophthalmic formulation for eye protection or treatment |
DE102005055577A1 (de) * | 2005-11-18 | 2007-05-24 | Merck Patent Gmbh | Flavone |
DE102006053360A1 (de) | 2006-11-10 | 2008-05-15 | Evonik Stockhausen Gmbh | Hautreinigungsmittel, insbesondere Kälteschutzcreme |
TW201036624A (en) * | 2009-03-27 | 2010-10-16 | Biotropics Malaysia Berhad | Aurones as selective PDE inhibitors and their use in neurological conditions and disorders |
FR2949781B1 (fr) * | 2009-09-04 | 2015-10-16 | Isp Investments Inc | Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable d'activer la transglutaminase. |
FR2949782B1 (fr) * | 2009-09-04 | 2015-10-16 | Isp Investments Inc | Peptide activateur de la transglutaminase et composition cosmetique ou pharmaceutique le contenant. |
FR3020800B1 (fr) * | 2014-05-09 | 2017-08-25 | Pierre Fabre Dermo-Cosmetique | Dispositif et procede de remplissage aseptique |
EA033761B1 (ru) * | 2014-09-30 | 2019-11-22 | Sicpa Holding Sa | Способ аутентификации жидкости путем обнаружения производных флавоноидов |
CN110339360B (zh) * | 2018-04-02 | 2024-04-19 | 苏中药业集团股份有限公司 | 瞬时受体电位阳离子通道trpv3在研制预防或治疗银屑病药物中的应用 |
US10639294B2 (en) | 2018-10-02 | 2020-05-05 | Janssen Pharmaceutica Nv | Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide metabolite |
US11304968B2 (en) | 2018-11-16 | 2022-04-19 | Janssen Pharmaceutica Nv | Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide |
-
2003
- 2003-12-05 DE DE10357004A patent/DE10357004A1/de not_active Withdrawn
-
2004
- 2004-11-05 JP JP2006541814A patent/JP2007513100A/ja active Pending
- 2004-11-05 US US10/581,494 patent/US7588783B2/en not_active Expired - Fee Related
- 2004-11-05 AT AT04819579T patent/ATE402158T1/de not_active IP Right Cessation
- 2004-11-05 DE DE502004007696T patent/DE502004007696D1/de active Active
- 2004-11-05 EP EP04819579A patent/EP1689734B1/de not_active Not-in-force
- 2004-11-05 WO PCT/EP2004/012538 patent/WO2005054222A2/de active IP Right Grant
- 2004-11-05 CN CN2004800361574A patent/CN1890232B/zh not_active Expired - Fee Related
- 2004-11-05 ES ES04819579T patent/ES2308311T3/es active Active
Non-Patent Citations (4)
Title |
---|
P. Ramesh,et al.A new flavone methyl ether from helicteres isora.J.NAT.PRODUCTS58 8.1995,58(8),1242-1243. |
P. Ramesh,et al.A new flavone methyl ether from helicteres isora.J.NAT.PRODUCTS58 8.1995,58(8),1242-1243. * |
Zong-Tsi Chen, et al.New flavoid glycosides of helicteres angustifolia.Heterocycles38 6.1994,38(6),1399-1406. |
Zong-Tsi Chen, et al.New flavoid glycosides of helicteres angustifolia.Heterocycles38 6.1994,38(6),1399-1406. * |
Also Published As
Publication number | Publication date |
---|---|
WO2005054222A3 (de) | 2005-08-11 |
ES2308311T3 (es) | 2008-12-01 |
WO2005054222A2 (de) | 2005-06-16 |
CN1890232A (zh) | 2007-01-03 |
EP1689734A2 (de) | 2006-08-16 |
US7588783B2 (en) | 2009-09-15 |
DE10357004A1 (de) | 2005-06-30 |
JP2007513100A (ja) | 2007-05-24 |
ATE402158T1 (de) | 2008-08-15 |
DE502004007696D1 (de) | 2008-09-04 |
EP1689734B1 (de) | 2008-07-23 |
US20070134172A1 (en) | 2007-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4850397B2 (ja) | クロメン−4−オン誘導体類の使用 | |
CN101437579B (zh) | 抗氧化剂 | |
KR100825450B1 (ko) | 연교추출물을 함유하는 피부 주름개선용 화장료 조성물 | |
JP2004115513A (ja) | 抗酸化剤性質を有する製剤 | |
JP5965915B2 (ja) | 2−ピロン | |
CN101001883A (zh) | 类黄酮络合物 | |
CN1890232B (zh) | 类黄酮衍生物 | |
KR101026879B1 (ko) | 피부주름개선용 화장료 조성물의 제조방법 | |
JP2011178770A (ja) | 皮膚の色素沈着を抑制する組成物およびその利用 | |
CN103179948A (zh) | 2,2’-联糠醛衍生物及其使皮肤增亮的用途 | |
KR102626704B1 (ko) | 장미꽃잎 추출물을 유효성분으로 포함하는 발모 촉진용 조성물 | |
KR102000550B1 (ko) | 신갈나무 화분으로부터 분리된 폴리아민계 화합물을 함유하는 미백용 조성물 | |
US20100028278A1 (en) | Use of chroman-4-one derivatives | |
CN105230865A (zh) | 排毒祛斑越桔茶 | |
KR102264006B1 (ko) | 멜라닌 생성 억제 및 분해 촉진용 조성물 | |
CN103889510A (zh) | 红果仔的提取物 | |
JP2023542556A (ja) | フラバノールモノマー及びe-ビニフェリンを含む組成物 | |
KR102105897B1 (ko) | 초고압 균질 공정을 통해 얻은 단풍취 추출물을 유효성분으로 함유하는 피부 미백용 조성물 | |
CN1938289A (zh) | 色酮配位化合物 | |
KR20210002046A (ko) | 구멍쇠미역 추출물을 포함하는 조성물 | |
TWI486176B (zh) | 落葵萃取物及其作為美白、防曬、抗老化、抗自由基、抗發炎之用途 | |
KR100813639B1 (ko) | 펜둘레틴을 유효성분으로 함유하는 피부 미백 조성물 | |
Zakaria et al. | Proliv Essence-3 (PE3): a nutricosmetic botanical blend as a dietary beverage for skin wellness and general health | |
KR100831419B1 (ko) | 간후안게닌을 유효성분으로 함유하는 피부 미백 조성물 | |
KR101711513B1 (ko) | 피부 개선용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: EUROPEAN BRAND CORPORATIONS Free format text: FORMER OWNER: MERCK PATENT GMBH Effective date: 20121130 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20121130 Address after: Luxemburg Luxemburg Patentee after: European brand cooperation Limited by Share Ltd Address before: Darmstadt Patentee before: Merck Patent GmbH |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100526 Termination date: 20131105 |